1) Chaturvedi AK et al : Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol 29 : 4294-4301, 2011.
2) NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Senior Adult Oncology Ver. 2. 2014.
3) Lassen P et al : Impact of HPV-associated p16-expression on radiotherapy outcome in advanced oropharynx and non-oropharynx cancer. Radiother Oncol 113 : 310-316, 2014.
4) Chen AM et al : Differential response rates to irradiation among patients with human papillomavirus positive and negative oropharyngeal cancer. Laryngoscope 123 : 152-157, 2013.
5) Quon H et al : Transoral robotic surgery and adjuvant therapy for oropharyngeal carcinomas and the influence of p16 INK4a on treatment outcomes. Laryngoscope 123 : 635-640, 2013.